Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 444 entries
Sorted by: Best Match Show Resources per page
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug.

Annals of general psychiatry

Mizushima J, Takahata K, Kawashima N, Kato M.
PMID: 22769562
Ann Gen Psychiatry. 2012 Jul 07;11(1):19. doi: 10.1186/1744-859X-11-19.

Dopamine dysregulation syndrome (DDS) consists of a series of complications such as compulsive use of dopaminergic medications, aggressive or hypomanic behaviors during excessive use, and withdrawal states characterized by dysphoria and anxiety, caused by long-term dopaminergic treatment in patients...

Cite
Mizushima J, Takahata K, Kawashima N, et al. Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug. Ann Gen Psychiatry. 2012;11(1):19doi: 10.1186/1744-859X-11-19.
Mizushima, J., Takahata, K., Kawashima, N., & Kato, M. (2012). Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug. Annals of general psychiatry, 11(1), 19. https://doi.org/10.1186/1744-859X-11-19
Mizushima, Jin, et al. "Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug." Annals of general psychiatry vol. 11,1 (2012): 19. doi: https://doi.org/10.1186/1744-859X-11-19
Mizushima J, Takahata K, Kawashima N, Kato M. Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug. Ann Gen Psychiatry. 2012 Jul 07;11(1):19. doi: 10.1186/1744-859X-11-19. PMID: 22769562; PMCID: PMC3465018.
Copy Download .nbib Format: NLM
Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus.

ISRN gastroenterology

Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Katano T, Ebi M, Mori Y, Kataoka H, Kamiya T, Joh T.
PMID: 23691335
ISRN Gastroenterol. 2013 Apr 09;2013:304894. doi: 10.1155/2013/304894. Print 2013.

Background. Tacrolimus (FK506) is effective for patients with ulcerative colitis (UC). However, there are few reports on tacrolimus therapy (TT) with respect to the relationship with endoscopic and clinicopathologic findings. Methods. Thirty patients with moderate/severe active UC refractory to...

Cite
Mizoshita T, Tanida S, Tsukamoto H, et al. Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus. ISRN Gastroenterol. 2013;2013:304894doi: 10.1155/2013/304894.
Mizoshita, T., Tanida, S., Tsukamoto, H., Ozeki, K., Katano, T., Ebi, M., Mori, Y., Kataoka, H., Kamiya, T., & Joh, T. (2013). Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus. ISRN gastroenterology, 2013304894. https://doi.org/10.1155/2013/304894
Mizoshita, Tsutomu, et al. "Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus." ISRN gastroenterology vol. 2013 (2013): 304894. doi: https://doi.org/10.1155/2013/304894
Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Katano T, Ebi M, Mori Y, Kataoka H, Kamiya T, Joh T. Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus. ISRN Gastroenterol. 2013 Apr 09;2013:304894. doi: 10.1155/2013/304894. Print 2013. PMID: 23691335; PMCID: PMC3649514.
Copy Download .nbib Format: NLM
Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review.

Oncology letters

Mokutani Y, Hata T, Miyake Y, Kuroda H, Takahashi H, Haraguchi N, Nishimura J, Mizushima T, Yamamoto H, Doki Y, Mori M.
PMID: 28454464
Oncol Lett. 2017 Apr;13(4):2765-2769. doi: 10.3892/ol.2017.5755. Epub 2017 Feb 21.

Primary hepatic angiosarcoma is a rare type of tumor with a poor prognosis. To the best of our knowledge, curative surgery of a metastatic gastrointestinal angiosarcoma from a hepatic angiosarcoma has not been reported previously. In the present report,...

Cite
Mokutani Y, Hata T, Miyake Y, et al. Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review. Oncol Lett. 2017;13(4):2765-2769doi: 10.3892/ol.2017.5755.
Mokutani, Y., Hata, T., Miyake, Y., Kuroda, H., Takahashi, H., Haraguchi, N., Nishimura, J., Mizushima, T., Yamamoto, H., Doki, Y., & Mori, M. (2017). Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review. Oncology letters, 13(4), 2765-2769. https://doi.org/10.3892/ol.2017.5755
Mokutani, Yukako, et al. "Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review." Oncology letters vol. 13,4 (2017): 2765-2769. doi: https://doi.org/10.3892/ol.2017.5755
Mokutani Y, Hata T, Miyake Y, Kuroda H, Takahashi H, Haraguchi N, Nishimura J, Mizushima T, Yamamoto H, Doki Y, Mori M. Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review. Oncol Lett. 2017 Apr;13(4):2765-2769. doi: 10.3892/ol.2017.5755. Epub 2017 Feb 21. PMID: 28454464; PMCID: PMC5403321.
Copy Download .nbib Format: NLM
Reply to the letter from Dr. Miao et al.

Physiological reports

Tanimura Y, Aoi W, Takanami Y, Kawai Y, Mizushima K, Naito Y, Yoshikawa T.
PMID: 27634109
Physiol Rep. 2016 Sep;4(17). doi: 10.14814/phy2.12964.

No abstract available.

Cite
Tanimura Y, Aoi W, Takanami Y, et al. Reply to the letter from Dr. Miao et al. Physiol Rep. 2016;4(17)doi: 10.14814/phy2.12964.
Tanimura, Y., Aoi, W., Takanami, Y., Kawai, Y., Mizushima, K., Naito, Y., & Yoshikawa, T. (2016). Reply to the letter from Dr. Miao et al. Physiological reports, 4(17), . https://doi.org/10.14814/phy2.12964
Tanimura, Yuko, et al. "Reply to the letter from Dr. Miao et al." Physiological reports vol. 4,17 (2016). doi: https://doi.org/10.14814/phy2.12964
Tanimura Y, Aoi W, Takanami Y, Kawai Y, Mizushima K, Naito Y, Yoshikawa T. Reply to the letter from Dr. Miao et al. Physiol Rep. 2016 Sep;4(17). doi: 10.14814/phy2.12964. PMID: 27634109; PMCID: PMC5027365.
Copy Download .nbib Format: NLM
[Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.

International journal of oncology

Yamamoto H, Oshiro R, Ohtsuka M, Uemura M, Haraguchi N, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M.
PMID: 27634111
Int J Oncol. 2016 Nov;49(5):2186. doi: 10.3892/ijo.2016.3694. Epub 2016 Sep 16.

Following the publication of this article, an interested reader drew to our attention an anomaly associated with the presen-tation of the Fig. 2D; specifically, there appeared to have been a duplication of the same β-actin control band for the...

Cite
Yamamoto H, Oshiro R, Ohtsuka M, et al. [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol. 2016;49(5):2186doi: 10.3892/ijo.2016.3694.
Yamamoto, H., Oshiro, R., Ohtsuka, M., Uemura, M., Haraguchi, N., Nishimura, J., Takemasa, I., Mizushima, T., Doki, Y., & Mori, M. (2016). [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. International journal of oncology, 49(5), 2186. https://doi.org/10.3892/ijo.2016.3694
Yamamoto, Hirofumi, et al. "[Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies." International journal of oncology vol. 49,5 (2016): 2186. doi: https://doi.org/10.3892/ijo.2016.3694
Yamamoto H, Oshiro R, Ohtsuka M, Uemura M, Haraguchi N, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M. [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol. 2016 Nov;49(5):2186. doi: 10.3892/ijo.2016.3694. Epub 2016 Sep 16. PMID: 27634111; PMCID: PMC5063454.
Copy Download .nbib Format: NLM
Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome.

Hepatology international

Obulhasim G, Yasen M, Kajino K, Mogushi K, Tanaka S, Mizushima H, Tanaka H, Arii S, Hino O.
PMID: 26201636
Hepatol Int. 2013 Mar;7(1):215-25. doi: 10.1007/s12072-012-9357-4. Epub 2012 Mar 13.

PURPOSE: Metabolic syndrome (MS) is a group of recognized risk factors for the development of hepatocellular carcinoma (HCC) in patients with chronic liver disease. The aim of this study was to analyze the clinicopathological characteristics of HCC patients with...

Cite
Obulhasim G, Yasen M, Kajino K, et al. Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome. Hepatol Int. 2012;7(1):215-25doi: 10.1007/s12072-012-9357-4.
Obulhasim, G., Yasen, M., Kajino, K., Mogushi, K., Tanaka, S., Mizushima, H., Tanaka, H., Arii, S., & Hino, O. (2013). Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome. Hepatology international, 7(1), 215-25. https://doi.org/10.1007/s12072-012-9357-4
Obulhasim, Gulanbar, et al. "Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome." Hepatology international vol. 7,1 (2013): 215-25. doi: https://doi.org/10.1007/s12072-012-9357-4
Obulhasim G, Yasen M, Kajino K, Mogushi K, Tanaka S, Mizushima H, Tanaka H, Arii S, Hino O. Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome. Hepatol Int. 2013 Mar;7(1):215-25. doi: 10.1007/s12072-012-9357-4. Epub 2012 Mar 13. PMID: 26201636.
Copy Download .nbib Format: NLM
Erratum to: Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.

Digestive diseases and sciences

Takeyama H, Mizushima T, Iijima H, Shinzaki S, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M.
PMID: 26264699
Dig Dis Sci. 2015 Dec;60(12):3827. doi: 10.1007/s10620-015-3829-z.

No abstract available.

Cite
Takeyama H, Mizushima T, Iijima H, et al. Erratum to: Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein. Dig Dis Sci. 2015;60(12):3827doi: 10.1007/s10620-015-3829-z.
Takeyama, H., Mizushima, T., Iijima, H., Shinzaki, S., Uemura, M., Nishimura, J., Hata, T., Takemasa, I., Yamamoto, H., Doki, Y., & Mori, M. (2015). Erratum to: Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein. Digestive diseases and sciences, 60(12), 3827. https://doi.org/10.1007/s10620-015-3829-z
Takeyama, Hiroshi, et al. "Erratum to: Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein." Digestive diseases and sciences vol. 60,12 (2015): 3827. doi: https://doi.org/10.1007/s10620-015-3829-z
Takeyama H, Mizushima T, Iijima H, Shinzaki S, Uemura M, Nishimura J, Hata T, Takemasa I, Yamamoto H, Doki Y, Mori M. Erratum to: Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein. Dig Dis Sci. 2015 Dec;60(12):3827. doi: 10.1007/s10620-015-3829-z. PMID: 26264699.
Copy Download .nbib Format: NLM
The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis.

Journal of clinical medicine research

Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T.
PMID: 25436030
J Clin Med Res. 2015 Feb;7(2):118-21. doi: 10.14740/jocmr1991w. Epub 2014 Nov 19.

A 43-year-old woman, diagnosed with ulcerative colitis (UC) at age of 30, received outpatient treatment with corticosteroids. However, flare-up occurred, and adalimumab (ADA) treatment commenced in July 2009. A complete remission with mucosal healing was achieved by 32 weeks...

Cite
Tanida S, Mizoshita T, Ozeki K, et al. The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis. J Clin Med Res. 2014;7(2):118-21doi: 10.14740/jocmr1991w.
Tanida, S., Mizoshita, T., Ozeki, K., Tsukamoto, H., Mori, Y., Kubota, E., Kataoka, H., Kamiya, T., & Joh, T. (2015). The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis. Journal of clinical medicine research, 7(2), 118-21. https://doi.org/10.14740/jocmr1991w
Tanida, Satoshi, et al. "The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis." Journal of clinical medicine research vol. 7,2 (2015): 118-21. doi: https://doi.org/10.14740/jocmr1991w
Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T. The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis. J Clin Med Res. 2015 Feb;7(2):118-21. doi: 10.14740/jocmr1991w. Epub 2014 Nov 19. PMID: 25436030; PMCID: PMC4245064.
Copy Download .nbib Format: NLM
Nanoscale layer-selective readout of magnetization direction from a magnetic multilayer using a spin-torque oscillator.

Nanotechnology

Suto H, Nagasawa T, Kudo K, Mizushima K, Sato R.
PMID: 24872254
Nanotechnology. 2014 Jun 20;25(24):245501. doi: 10.1088/0957-4484/25/24/245501.

Technology for detecting the magnetization direction of nanoscale magnetic material is crucial for realizing high-density magnetic recording devices. Conventionally, a magnetoresistive device is used that changes its resistivity in accordance with the direction of the stray field from an...

Cite
Suto H, Nagasawa T, Kudo K, et al. Nanoscale layer-selective readout of magnetization direction from a magnetic multilayer using a spin-torque oscillator. Nanotechnology. 2014;25(24):245501doi: 10.1088/0957-4484/25/24/245501.
Suto, H., Nagasawa, T., Kudo, K., Mizushima, K., & Sato, R. (2014). Nanoscale layer-selective readout of magnetization direction from a magnetic multilayer using a spin-torque oscillator. Nanotechnology, 25(24), 245501. https://doi.org/10.1088/0957-4484/25/24/245501
Suto, Hirofumi, et al. "Nanoscale layer-selective readout of magnetization direction from a magnetic multilayer using a spin-torque oscillator." Nanotechnology vol. 25,24 (2014): 245501. doi: https://doi.org/10.1088/0957-4484/25/24/245501
Suto H, Nagasawa T, Kudo K, Mizushima K, Sato R. Nanoscale layer-selective readout of magnetization direction from a magnetic multilayer using a spin-torque oscillator. Nanotechnology. 2014 Jun 20;25(24):245501. doi: 10.1088/0957-4484/25/24/245501. PMID: 24872254.
Copy Download .nbib Format: NLM
Growing concerns with the flow of misinformation from electronic books.

Interactive journal of medical research

Takahashi K, Kanda H, Mizushima S.
PMID: 23709125
Interact J Med Res. 2013 May 24;2(1):e10. doi: 10.2196/ijmr.2541.

In 2012, several kinds of electronic books (e-books) became available in Japan. Since several major book retailers launched e-book businesses, it is expected that e-books will become a popular source of information in the country. However, we are concerned...

Cite
Takahashi K, Kanda H, Mizushima S. Growing concerns with the flow of misinformation from electronic books. Interact J Med Res. 2013;2(1):e10doi: 10.2196/ijmr.2541.
Takahashi, K., Kanda, H., & Mizushima, S. (2013). Growing concerns with the flow of misinformation from electronic books. Interactive journal of medical research, 2(1), e10. https://doi.org/10.2196/ijmr.2541
Takahashi, Kenzo, et al. "Growing concerns with the flow of misinformation from electronic books." Interactive journal of medical research vol. 2,1 (2013): e10. doi: https://doi.org/10.2196/ijmr.2541
Takahashi K, Kanda H, Mizushima S. Growing concerns with the flow of misinformation from electronic books. Interact J Med Res. 2013 May 24;2(1):e10. doi: 10.2196/ijmr.2541. PMID: 23709125; PMCID: PMC3668616.
Copy Download .nbib Format: NLM
Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects.

Clinical obesity

Yamakado M, Tanaka T, Nagao K, Ishizaka Y, Mitushima T, Tani M, Toda A, Toda E, Okada M, Miyano H, Yamamoto H.
PMID: 25586045
Clin Obes. 2012 Feb;2(1):29-40. doi: 10.1111/j.1758-8111.2012.00039.x. Epub 2012 May 22.

UNLABELLED: What is already known about this subject •  Asians with metabolic complications associated with obesity, a low body mass index and a low waist circumference have a greater proportion of visceral adipose tissue for a given amount of...

Cite
Yamakado M, Tanaka T, Nagao K, et al. Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects. Clin Obes. 2012;2(1):29-40doi: 10.1111/j.1758-8111.2012.00039.x.
Yamakado, M., Tanaka, T., Nagao, K., Ishizaka, Y., Mitushima, T., Tani, M., Toda, A., Toda, E., Okada, M., Miyano, H., & Yamamoto, H. (2012). Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects. Clinical obesity, 2(1), 29-40. https://doi.org/10.1111/j.1758-8111.2012.00039.x
Yamakado, M, et al. "Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects." Clinical obesity vol. 2,1 (2012): 29-40. doi: https://doi.org/10.1111/j.1758-8111.2012.00039.x
Yamakado M, Tanaka T, Nagao K, Ishizaka Y, Mitushima T, Tani M, Toda A, Toda E, Okada M, Miyano H, Yamamoto H. Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects. Clin Obes. 2012 Feb;2(1):29-40. doi: 10.1111/j.1758-8111.2012.00039.x. Epub 2012 May 22. PMID: 25586045.
Copy Download .nbib Format: NLM
Successful treatment of rectal cancer with perineal invasion: Three case reports.

Molecular and clinical oncology

Kitahara T, Uemura M, Haraguchi N, Nishimura J, Shingai T, Hata T, Takemasa I, Mizushima T, Doki Y, Mori M, Yamamoto H.
PMID: 24940483
Mol Clin Oncol. 2014 Jul;2(4):497-500. doi: 10.3892/mco.2014.282. Epub 2014 Apr 17.

Rectal cancer occasionally invades adjacent organs. However, rectal cancer with perineal invasion is uncommon and difficult to treat. Locally advanced colorectal cancer may be clinically treated with neoadjuvant therapy, followed by en bloc resection. Skin invasion may lead to...

Cite
Kitahara T, Uemura M, Haraguchi N, et al. Successful treatment of rectal cancer with perineal invasion: Three case reports. Mol Clin Oncol. 2014;2(4):497-500doi: 10.3892/mco.2014.282.
Kitahara, T., Uemura, M., Haraguchi, N., Nishimura, J., Shingai, T., Hata, T., Takemasa, I., Mizushima, T., Doki, Y., Mori, M., & Yamamoto, H. (2014). Successful treatment of rectal cancer with perineal invasion: Three case reports. Molecular and clinical oncology, 2(4), 497-500. https://doi.org/10.3892/mco.2014.282
Kitahara, Tomohiro, et al. "Successful treatment of rectal cancer with perineal invasion: Three case reports." Molecular and clinical oncology vol. 2,4 (2014): 497-500. doi: https://doi.org/10.3892/mco.2014.282
Kitahara T, Uemura M, Haraguchi N, Nishimura J, Shingai T, Hata T, Takemasa I, Mizushima T, Doki Y, Mori M, Yamamoto H. Successful treatment of rectal cancer with perineal invasion: Three case reports. Mol Clin Oncol. 2014 Jul;2(4):497-500. doi: 10.3892/mco.2014.282. Epub 2014 Apr 17. PMID: 24940483; PMCID: PMC4051571.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 444 entries